Trial
NCT02282163
Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
Phase IIITERMINATEDREGULATORYConfidence: HIGH
Sponsor
Bracco Diagnostics, Inc
Collaborators
—
Condition
Heart Disease
Intervention
sulphur hexafluoride lipid-type A microspheres
Why stopped
FDA agreed to early termination due to difficulties enrolling patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-13